Retatrutide + Cagrilintide is a co-formulated research combination pairing Retatrutide, a 39-residue GIP/GLP-1/glucagon triple-receptor agonist peptide, with Cagrilintide, a 32-residue long-acting amylin analogue. It is supplied as a lyophilized research-grade material for laboratory use only.

Tirzepatide is a synthetic 39-amino-acid, lipid-conjugated peptide (CAS 2023788-19-2) engineered as a dual agonist of the GIP and GLP-1 receptors, supplied as a research-grade lyophilized material for laboratory use only.

Semaglutide is a synthetic 31-residue GLP-1 receptor agonist analog (CAS 910463-68-2) carrying an Aib substitution at position 2 and a fatty-diacid side chain at Lys26. It is supplied as a lyophilized research-grade peptide for laboratory use only.

Retatrutide (RETA) is a synthetic 39-amino-acid, lipid-conjugated peptide (CAS 2381089-83-2) classified as a unimolecular GIP/GLP-1/glucagon triple receptor agonist, supplied as a lyophilized research-grade solid at ≥99% HPLC purity for laboratory use only.